Erratum to: Phase II study of selumetinib (AZD6244, ARRY-142886) plus irinotecan as second-line therapy in patients with K-RAS mutated colorectal cancer
Titel:
Erratum to: Phase II study of selumetinib (AZD6244, ARRY-142886) plus irinotecan as second-line therapy in patients with K-RAS mutated colorectal cancer
Auteur:
Hochster, H. S. Uboha, N. Messersmith, W. Gold, P. J. ONeil, B. H. Cohen, D. Denlinger, C. Cohen, S. Leichman, C. G. Leichman, L. Lenz, H.-J.